Pacsin 2-dependent N-cadherin internalization regulates the migration behaviour of malignant cancer cells.


Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
15 05 2023
Historique:
received: 22 11 2022
accepted: 13 04 2023
medline: 1 6 2023
pubmed: 3 5 2023
entrez: 3 5 2023
Statut: ppublish

Résumé

Collective cell migration is the coordinated movement of multiple cells connected by cadherin-based adherens junctions and is essential for physiological and pathological processes. Cadherins undergo dynamic intracellular trafficking, and their surface level is determined by a balance between endocytosis, recycling and degradation. However, the regulatory mechanism of cadherin turnover in collective cell migration remains elusive. In this study, we show that the Bin/amphiphysin/Rvs (BAR) domain protein pacsin 2 (protein kinase C and casein kinase substrate in neurons protein 2) plays an essential role in collective cell migration by regulating N-cadherin (also known as CDH2) endocytosis in human cancer cells. Pacsin 2-depleted cells formed cell-cell contacts enriched with N-cadherin and migrated in a directed manner. Furthermore, pacsin 2-depleted cells showed attenuated internalization of N-cadherin from the cell surface. Interestingly, GST pull-down assays demonstrated that the pacsin 2 SH3 domain binds to the cytoplasmic region of N-cadherin, and expression of an N-cadherin mutant defective in binding to pacsin 2 phenocopied pacsin 2 RNAi cells both in cell contact formation and N-cadherin endocytosis. These data support new insights into a novel endocytic route of N-cadherin in collective cell migration, highlighting pacsin 2 as a possible therapeutic target for cancer metastasis.

Identifiants

pubmed: 37132654
pii: 307447
doi: 10.1242/jcs.260827
pmc: PMC10281519
pii:
doi:

Substances chimiques

Cadherins 0
PACSIN2 protein, human 0
Adaptor Proteins, Signal Transducing 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Nat Cell Biol. 2005 Jun;7(6):581-90
pubmed: 15895076
PLoS One. 2012;7(12):e52401
pubmed: 23285027
J Biol Chem. 2003 Jun 6;278(23):21050-7
pubmed: 12657640
J Cell Sci. 2011 Jul 15;124(Pt 14):2375-88
pubmed: 21693584
Biochem Biophys Res Commun. 2021 Sep 24;571:145-151
pubmed: 34325130
Traffic. 2016 Dec;17(12):1262-1271
pubmed: 27624909
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
FEBS Lett. 2009 Apr 17;583(8):1337-43
pubmed: 19306879
Am J Transl Res. 2019 Sep 15;11(9):5301-5312
pubmed: 31632511
Acta Physiol (Oxf). 2022 Mar;234(3):e13783
pubmed: 34990060
J Cell Biol. 2002 Nov 11;159(3):465-76
pubmed: 12427869
Nat Cell Biol. 2006 Nov;8(11):1223-34
pubmed: 17060906
J Urol. 2011 May;185(5):1930-8
pubmed: 21421245
Mol Cell Biochem. 2020 Aug;471(1-2):113-127
pubmed: 32519230
Biochim Biophys Acta. 2007 Jan;1773(1):2-7
pubmed: 17175391
J Cell Sci. 2007 May 15;120(Pt 10):1818-28
pubmed: 17502486
Biophys J. 2022 Jan 4;121(1):44-60
pubmed: 34890578
Int J Mol Sci. 2020 Oct 15;21(20):
pubmed: 33076339
BMC Cancer. 2018 Oct 1;18(1):939
pubmed: 30285678
J Biol Chem. 2021 Jan-Jun;296:100077
pubmed: 33187981
Nat Rev Mol Cell Biol. 2019 Dec;20(12):738-752
pubmed: 31582855
Mol Biol Cell. 2001 Apr;12(4):847-62
pubmed: 11294891
J Cell Sci. 2012 Aug 1;125(Pt 15):3661-70
pubmed: 22467866
J Cell Biol. 2003 Nov 10;163(3):525-34
pubmed: 14610055
Oncogene. 2016 Feb 25;35(8):952-64
pubmed: 26028032
Nat Cell Biol. 1999 May;1(1):33-9
pubmed: 10559861
Nat Rev Mol Cell Biol. 2012 Oct;13(10):673-9
pubmed: 22931853
PLoS Pathog. 2016 Dec 12;12(12):e1006070
pubmed: 27942025
J Cell Biol. 2011 Jun 27;193(7):1137-46
pubmed: 21708975
Trends Cell Biol. 2015 Sep;25(9):556-66
pubmed: 26137890
J Cell Sci. 2011 May 15;124(Pt 10):1739-51
pubmed: 21525036
J Biol Chem. 2003 May 23;278(21):19199-208
pubmed: 12626512
Dev Cell. 2010 Jul 20;19(1):39-53
pubmed: 20643349
Nat Rev Mol Cell Biol. 2009 Jul;10(7):445-57
pubmed: 19546857
BMC Cancer. 2018 Apr 18;18(1):441
pubmed: 29669530
Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
pubmed: 16493418
Annu Rev Cell Dev Biol. 2009;25:407-29
pubmed: 19575657
Nat Rev Mol Cell Biol. 2005 Aug;6(8):622-34
pubmed: 16025097
J Biol Chem. 2007 Apr 13;282(15):11540-8
pubmed: 17298950
Nat Commun. 2013;4:1589
pubmed: 23481397
J Cell Sci. 2005 Mar 1;118(Pt 5):873-87
pubmed: 15713751
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Biol Chem. 2005 Jan 21;280(3):2220-8
pubmed: 15528189
Nat Commun. 2016 Jul 15;7:12210
pubmed: 27417273
Nat Commun. 2021 May 10;12(1):2610
pubmed: 33972531
Science. 2004 Jan 23;303(5657):495-9
pubmed: 14645856
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
EMBO J. 2000 Aug 15;19(16):4272-80
pubmed: 10944110
J Neurosci. 2014 Aug 6;34(32):10688-700
pubmed: 25100601
Oncotarget. 2016 Jan 26;7(4):4110-21
pubmed: 26684027
Cancer Cell. 2003 Dec;4(6):499-515
pubmed: 14706341
J Cell Biol. 2000 Mar 6;148(5):1047-62
pubmed: 10704453
Small GTPases. 2020 Mar;11(2):103-112
pubmed: 28980871
J Cell Sci. 2011 Jun 15;124(Pt 12):2032-40
pubmed: 21610094
J Cell Sci. 2008 Mar 15;121(Pt 6):727-35
pubmed: 18322269
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Biochem Biophys Res Commun. 2016 Nov 18;480(3):409-414
pubmed: 27771248
Genes Dev. 2000 May 15;14(10):1169-80
pubmed: 10817752
J Cell Biol. 2016 Jan 18;212(2):199-217
pubmed: 26783302
J Cell Biol. 2023 Feb 6;222(2):
pubmed: 36571786
Nature. 2008 Dec 18;456(7224):957-61
pubmed: 19078960
Oncogene. 2017 Oct 19;36(42):5840-5851
pubmed: 28628116
J Biol Chem. 2012 Dec 21;287(52):43438-53
pubmed: 23129763
Mol Biol Cell. 2011 May;22(9):1529-38
pubmed: 21411625
Membranes (Basel). 2012 Feb 27;2(1):91-117
pubmed: 24957964
iScience. 2018 Sep 28;7:53-67
pubmed: 30267686
Subcell Biochem. 2012;60:197-222
pubmed: 22674073
Eur J Clin Invest. 2016 Dec;46(12):1002-1011
pubmed: 27696383
J Cell Biol. 1999 Jul 12;146(1):219-32
pubmed: 10402472
Cell Cycle. 2011 Jan 1;10(1):73-81
pubmed: 21200149
J Cell Sci. 2000 Dec;113 Pt 24:4511-21
pubmed: 11082044
Traffic. 2017 May;18(5):287-303
pubmed: 28224728
J Cell Sci. 2016 Mar 15;129(6):1093-100
pubmed: 26919980
Biochem J. 2003 Apr 15;371(Pt 2):463-71
pubmed: 12570871
EMBO J. 2013 Oct 16;32(20):2722-34
pubmed: 24076656
PLoS One. 2013;8(1):e55069
pubmed: 23359820
Cancer Res. 2010 Nov 1;70(21):8347-56
pubmed: 20940394
Mol Biol Cell. 2005 Jan;16(1):14-23
pubmed: 15509650
Mol Oncol. 2017 Jan;11(1):5-27
pubmed: 28085224
Nature. 2021 Dec;600(7890):690-694
pubmed: 34880503
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Front Mol Biosci. 2021 Aug 05;8:696072
pubmed: 34422904
Nat Cell Biol. 2016 Dec;18(12):1311-1323
pubmed: 27842057
Genes Dev. 2006 Dec 1;20(23):3199-214
pubmed: 17158740
Pathol Int. 2016 Apr;66(4):183-92
pubmed: 26897041
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
J Cell Biol. 1998 Apr 6;141(1):85-99
pubmed: 9531550
Nat Commun. 2017 Apr 12;8:14923
pubmed: 28401884
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Cell Sci. 2011 Aug 15;124(Pt 16):2777-85
pubmed: 21807942
J Cell Biol. 2003 Nov 10;163(3):535-45
pubmed: 14610056
Circ Res. 2008 Aug 15;103(4):405-12
pubmed: 18617695
EMBO J. 2011 Aug 31;30(17):3501-15
pubmed: 21878992
Open Biol. 2013 Aug 07;3(8):130081
pubmed: 23926047
Mol Biol Cell. 2009 Apr;20(7):1970-80
pubmed: 19211843

Auteurs

Haymar Wint (H)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.

Jianzhen Li (J)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.
Laboratory for Neural Cell Dynamics, RIKEN Center for Brain Science, Hirosawa 2-1, Wako, Saitama 351-0198, Japan.

Tadashi Abe (T)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.

Hiroshi Yamada (H)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.

Takumi Higaki (T)

Faculty of Advanced Science and Technology, Kumamoto University, Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
International Research Organization for Advanced Science and Technology , Kumamoto University, Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.

Yasutomo Nasu (Y)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Masami Watanabe (M)

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Kohji Takei (K)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.

Tetsuya Takeda (T)

Department of Neuroscience, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata-cho 2-5-1, Kita-ku, Okayama 700-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH